218 related articles for article (PubMed ID: 35477522)
1. Functional interaction between endothelin-1 and ZEB1/YAP signaling regulates cellular plasticity and metastasis in high-grade serous ovarian cancer.
Sestito R; Tocci P; Roman C; Di Castro V; Bagnato A
J Exp Clin Cancer Res; 2022 Apr; 41(1):157. PubMed ID: 35477522
[TBL] [Abstract][Full Text] [Related]
2. β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer.
Tocci P; Cianfrocca R; Di Castro V; Rosanò L; Sacconi A; Donzelli S; Bonfiglio S; Bucci G; Vizza E; Ferrandina G; Scambia G; Tonon G; Blandino G; Bagnato A
Nat Commun; 2019 Jul; 10(1):3196. PubMed ID: 31324767
[TBL] [Abstract][Full Text] [Related]
3. Targeting tumor-stroma communication by blocking endothelin-1 receptors sensitizes high-grade serous ovarian cancer to PARP inhibition.
Tocci P; Roman C; Sestito R; Di Castro V; Sacconi A; Molineris I; Paolini F; Carosi M; Tonon G; Blandino G; Bagnato A
Cell Death Dis; 2023 Jan; 14(1):5. PubMed ID: 36604418
[TBL] [Abstract][Full Text] [Related]
4. Targeting endothelin 1 receptor-miR-200b/c-ZEB1 circuitry blunts metastatic progression in ovarian cancer.
Sestito R; Cianfrocca R; Tocci P; Rosanò L; Sacconi A; Blandino G; Bagnato A
Commun Biol; 2020 Nov; 3(1):677. PubMed ID: 33188287
[TBL] [Abstract][Full Text] [Related]
5. hMENA is a key regulator in endothelin-1/β-arrestin1-induced invadopodial function and metastatic process.
Di Modugno F; Caprara V; Chellini L; Tocci P; Spadaro F; Ferrandina G; Sacconi A; Blandino G; Nisticò P; Bagnato A; Rosanò L
Proc Natl Acad Sci U S A; 2018 Mar; 115(12):3132-3137. PubMed ID: 29439204
[TBL] [Abstract][Full Text] [Related]
6. The interaction of β-arrestin1 with talin1 driven by endothelin A receptor as a feature of α5β1 integrin activation in high-grade serous ovarian cancer.
Masi I; Ottavi F; Del Rio D; Caprara V; Vastarelli C; Giannitelli SM; Fianco G; Mozetic P; Buttarelli M; Ferrandina G; Scambia G; Gallo D; Rainer A; Bagnato A; Spadaro F; Rosanò L
Cell Death Dis; 2023 Jan; 14(1):73. PubMed ID: 36717550
[TBL] [Abstract][Full Text] [Related]
7. Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer.
Liu M; Zhang Y; Yang J; Zhan H; Zhou Z; Jiang Y; Shi X; Fan X; Zhang J; Luo W; Fung KA; Xu C; Bronze MS; Houchen CW; Li M
Gastroenterology; 2021 Apr; 160(5):1771-1783.e1. PubMed ID: 33421513
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
Bagnato A; Rosanò L
Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
[TBL] [Abstract][Full Text] [Related]
9. Regulation of extracellular matrix degradation and metastatic spread by IQGAP1 through endothelin-1 receptor signalling in ovarian cancer.
Chellini L; Caprara V; Spadaro F; Sestito R; Bagnato A; Rosanò L
Matrix Biol; 2019 Aug; 81():17-33. PubMed ID: 30367951
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-1 drives invadopodia and interaction with mesothelial cells through ILK.
Masi I; Caprara V; Spadaro F; Chellini L; Sestito R; Zancla A; Rainer A; Bagnato A; Rosanò L
Cell Rep; 2021 Mar; 34(9):108800. PubMed ID: 33657382
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
[TBL] [Abstract][Full Text] [Related]
12. Endothelin A receptor/β-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapy.
Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Caprara V; Semprucci E; Ferrandina G; Natali PG; Bagnato A
Cancer Res; 2014 Dec; 74(24):7453-64. PubMed ID: 25377471
[TBL] [Abstract][Full Text] [Related]
13. Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer.
Cianfrocca R; Rosanò L; Tocci P; Sestito R; Caprara V; Di Castro V; De Maria R; Bagnato A
Cell Death Differ; 2017 Oct; 24(10):1811-1820. PubMed ID: 28708138
[TBL] [Abstract][Full Text] [Related]
14. YAP and endothelin-1 signaling: an emerging alliance in cancer.
Tocci P; Blandino G; Bagnato A
J Exp Clin Cancer Res; 2021 Jan; 40(1):27. PubMed ID: 33422090
[TBL] [Abstract][Full Text] [Related]
15. LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression.
Liang H; Yu T; Han Y; Jiang H; Wang C; You T; Zhao X; Shan H; Yang R; Yang L; Shan H; Gu Y
Mol Cancer; 2018 Aug; 17(1):119. PubMed ID: 30098599
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-1 axis fosters YAP-induced chemotherapy escape in ovarian cancer.
Tocci P; Cianfrocca R; Sestito R; Rosanò L; Di Castro V; Blandino G; Bagnato A
Cancer Lett; 2020 Nov; 492():84-95. PubMed ID: 32860850
[TBL] [Abstract][Full Text] [Related]
17. miR-1236-3p represses the cell migration and invasion abilities by targeting ZEB1 in high-grade serous ovarian carcinoma.
Wang Y; Yan S; Liu X; Zhang W; Li Y; Dong R; Zhang Q; Yang Q; Yuan C; Shen K; Kong B
Oncol Rep; 2014 Apr; 31(4):1905-10. PubMed ID: 24573236
[TBL] [Abstract][Full Text] [Related]
18. β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells.
Cianfrocca R; Tocci P; Semprucci E; Spinella F; Di Castro V; Bagnato A; Rosanò L
Life Sci; 2014 Nov; 118(2):179-84. PubMed ID: 24530737
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide cooperation of EMT transcription factor ZEB1 with YAP and AP-1 in breast cancer.
Feldker N; Ferrazzi F; Schuhwerk H; Widholz SA; Guenther K; Frisch I; Jakob K; Kleemann J; Riegel D; Bönisch U; Lukassen S; Eccles RL; Schmidl C; Stemmler MP; Brabletz T; Brabletz S
EMBO J; 2020 Sep; 39(17):e103209. PubMed ID: 32692442
[TBL] [Abstract][Full Text] [Related]
20. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
[Next] [New Search]